Last update:
Oncology news
FDA warns biotech firm over cancer drug claims
The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.
4 hours ago
0
0
AI model can predict chemotherapy benefit in breast cancer
Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from ...
23 hours ago
0
17
Immunotherapy plus chemo cuts stage three dMMR colon cancer recurrence by 50%
Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped prevent and detect it ...
18 hours ago
0
2
Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036
Research from The Australian National University (ANU) and The University of Sydney (USYD) reveals cervical cancer among Aboriginal and Torres Strait Islander peoples will not be eliminated without urgent and targeted action ...
21 hours ago
0
1
Spatial mapping technique allows researchers to understand tumor architecture
Tumors contain many different types of cells organized in complex spatial patterns that can influence how the disease progresses. Because of this, it is hard to predict how a tumor will develop and respond to treatment. Researchers ...
Mar 28, 2026
0
4
AI-powered 'lab-on-a-chip' platform may enable same-day treatment decisions for pediatric patients
Scientists at the University of Utah (the U) have developed a new "lab-on-a-chip" device that uses artificial intelligence to rapidly predict cancer cell sensitivity to targeted therapies for children with T-cell acute lymphoblastic ...
Mar 27, 2026
0
9
AI learns to make sense of childhood cancer survivors' health care needs
Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the more information included in AI prompting, the better its performance. This finding, published in Communications ...
Mar 27, 2026
0
3
Molecular test for bile duct cancer nearly doubles detection rate
When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must determine whether the cause is cancer or a benign condition. The location of these ...
Mar 27, 2026
0
5
Study finds a U-shaped link between ovarian cancer diagnosis time and survival
Ovarian cancer is hard to diagnose early. Its symptoms, like bloating and abdominal pain, are vague and similar to other more common conditions. Early diagnosis improves outcomes for many cancers. However, prior research ...
Mar 27, 2026
0
3
Triple pre-surgery therapy may boost immunity against soft tissue sarcoma
Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and Stanford Medicine suggest that combining targeted radiation therapy with an experimental ...
Mar 27, 2026
0
4
Proteomic signatures link physical activity to lower risks of cancer, cardiometabolic diseases and multimorbidity
A new epidemiological study led by researchers at the International Agency for Research on Cancer (IARC) and the University of Regensburg, Germany, provides new clues about how physical activity helps prevent chronic diseases ...
Mar 27, 2026
0
4
Can marijuana cause lung cancer?
As more states legalize marijuana, many people might be wondering if that means it is safe to use. While smoking tobacco is a known and well-studied cause of lung cancer, linking marijuana to cancer is more complicated, says ...
Mar 27, 2026
0
9
Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows
New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk ...
Mar 27, 2026
0
4
New study uncovers mechanism explaining how obesity increases cancer risk
Scientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining excess weight increases your risk of cancer. City of Hope is one of the largest and most advanced cancer ...
Mar 27, 2026
0
4
Why some cancer therapies don't work for all patients: A tumor backup survival pathway
Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they typically work for only 40% to 80% of the patients who would be expected to respond to them. In a ...
Mar 26, 2026
0
8
Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers
A team of cancer genomics scientists from The University of Manchester and The Institute of Cancer Research, London, forensically examined the genetic make-up of tumors in 16 different cancers. Their findings, which have ...
Mar 26, 2026
0
9
A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment
In 2023, researchers at Baylor College of Medicine led by the late Dr. Bert O'Malley discovered that the steroid receptor coactivator 3 (SRC-3) in immune cells called regulatory T cells (Tregs) plays a decisive role in shaping ...
Mar 26, 2026
0
5
3D-printed ATLAS platform helps model cancer cell clusters behind metastasis
Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part because researchers lack reliable ways to recreate the conditions cancer cells encounter as they ...
Mar 26, 2026
0
4
Tumor DNA circulating in patients' blood after pre-surgery treatments predicts whether breast cancer will return
Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery. ...
Mar 26, 2026
0
9
Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference (EBCC15) in Barcelona.
Mar 26, 2026
0
5
Practical recommendations to strengthen cancer microbiome research
An international team led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and A*STAR Genome Institute of Singapore (A*STAR GIS), has published a paper in Nature Cancer ...
Mar 26, 2026
0
4
MetaRing quickly identifies breast cancer drug sensitivity
Recently, a research team led by Prof. Wang Hongzhi from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has developed a programmable plasmonic ring biosensor, MetaRing, capable of rapidly and accurately ...
Mar 26, 2026
0
5
DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors
The dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of Science Tokyo. Using surgical specimens and patient-derived ...
Mar 26, 2026
0
3
Breast cancer hijacks the lung repair system to fuel tumor growth, study finds
Researchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take advantage of the body's natural healing response and how a commonly used drug might slow that process. ...
Mar 26, 2026
0
5
A machine learning model may enable liver cancer risk prediction with routine clinical information
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, ...
Mar 26, 2026
0
3
